DK549589D0 - Neoglycoproteiner, deres fremstilling og anvendelse - Google Patents

Neoglycoproteiner, deres fremstilling og anvendelse

Info

Publication number
DK549589D0
DK549589D0 DK549589A DK549589A DK549589D0 DK 549589 D0 DK549589 D0 DK 549589D0 DK 549589 A DK549589 A DK 549589A DK 549589 A DK549589 A DK 549589A DK 549589 D0 DK549589 D0 DK 549589D0
Authority
DK
Denmark
Prior art keywords
neoglycoproteins
neoglycoproteines
preparation
monosialolactose
disialolactose
Prior art date
Application number
DK549589A
Other languages
English (en)
Other versions
DK549589A (da
Inventor
Herbert Wiegand
Silke Bosslet
Klaus Bosslet
Hans Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK549589D0 publication Critical patent/DK549589D0/da
Publication of DK549589A publication Critical patent/DK549589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK549589A 1988-11-05 1989-11-03 Neoglycoproteiner, deres fremstilling og anvendelse DK549589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3837623A DE3837623A1 (de) 1988-11-05 1988-11-05 Neoglykoproteine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
DK549589D0 true DK549589D0 (da) 1989-11-03
DK549589A DK549589A (da) 1990-05-06

Family

ID=6366580

Family Applications (1)

Application Number Title Priority Date Filing Date
DK549589A DK549589A (da) 1988-11-05 1989-11-03 Neoglycoproteiner, deres fremstilling og anvendelse

Country Status (12)

Country Link
EP (1) EP0368131B1 (da)
JP (1) JP2838147B2 (da)
KR (1) KR0162635B1 (da)
AT (1) ATE142229T1 (da)
AU (1) AU630634B2 (da)
CA (1) CA2002218C (da)
DE (2) DE3837623A1 (da)
DK (1) DK549589A (da)
ES (1) ES2093612T3 (da)
GR (1) GR3021111T3 (da)
IE (1) IE76312B1 (da)
PT (1) PT92187B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
EP0646377A1 (en) * 1993-10-01 1995-04-05 LUANFARMA S.r.l. Albumin-conjugated tumour cell-free extracts, antigenic compositions comprising the same, related antibodies, and uses thereof
US5935821A (en) * 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5612030A (en) 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US6008203A (en) * 1995-07-14 1999-12-28 Glycotech Corp. Methods for treatment of EGF receptor associated cancers
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same
DE3840044A1 (de) * 1988-11-27 1990-06-07 Behringwerke Ag Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung

Also Published As

Publication number Publication date
PT92187A (pt) 1990-05-31
ATE142229T1 (de) 1996-09-15
KR900007429A (ko) 1990-06-01
KR0162635B1 (ko) 1998-11-16
JPH02173000A (ja) 1990-07-04
CA2002218C (en) 2000-08-08
AU4436889A (en) 1990-05-10
DK549589A (da) 1990-05-06
IE893548L (en) 1990-05-05
EP0368131A3 (en) 1990-12-19
GR3021111T3 (en) 1996-12-31
IE76312B1 (en) 1997-10-22
EP0368131A2 (de) 1990-05-16
EP0368131B1 (de) 1996-09-04
DE3837623A1 (de) 1990-05-10
CA2002218A1 (en) 1990-05-05
PT92187B (pt) 1995-06-30
DE58909720D1 (de) 1996-10-10
JP2838147B2 (ja) 1998-12-16
AU630634B2 (en) 1992-11-05
ES2093612T3 (es) 1997-01-01

Similar Documents

Publication Publication Date Title
NO831317L (no) Fremgangsmaate for fremstilling av funksjonelle menneske-urokinase proteiner.
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
DE69329538T2 (de) Chlorophyll- und Bakteriochlorophyll-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen
FI885543A (fi) Dna-segment, polypeptider och anti-kroppar anslutande till human vaevnadsfaktor.
DE3873397D1 (de) Bifunktionelle proteine.
GR3005768T3 (da)
DK549589A (da) Neoglycoproteiner, deres fremstilling og anvendelse
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
DK402485D0 (da) Tumorterapeutiskum og fremgangsmaade til dets fremstilling
DK304090A (da) Glycerolderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
ATE160359T1 (de) Antigene regionen von tumorfreigestzten partikeln (tlp) komplexen und antikörper die sie erkennen.
DK493988D0 (da) 4-oxo-3-quinolincarboxylsyrer, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse forbindelser
ZA875676B (en) The use of 15-deoxyspergualine as a pharmaceutical
DK299590A (da) Phospholipidderivater, fremgangsmaade til deres fremstilling og terapeutiske praeparater indeholdende disse
IT1192016B (it) Procedimento perfezionato per la confezione di libri composti di segnature cucite
DE3784364T2 (de) Tumorassoziiertes antigen.
ATE95426T1 (de) Humanes karcinom-assoziertes antigen und an dieses antigen bindende antikoerper.
NO883674D0 (no) 5-hydroksy-3-aminokroman-forbindelser, fremgangsmaater for deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelsene og metoder for behandling dermed.
NO2002015I1 (no) Human tumornekrosefaktorreseptor p 75 Fc fusjonsprotein

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment